Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammatory myopathy in thyrotoxicosis

O Hardiman1, F Molloy, F Brett

  • 1Neuromuscular Clinic, Richmond Institute of Neurology and Neurosurgery, Beaumont Hospital, Dublin, Ireland.

Neurology
|February 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuroimaging confirms selective cerebral involvement in primary lateral sclerosis and predilection to brain regions with high metabolic activity.

Revue neurologique·2026
Same author

Vacuolar leucoencephalopathy and pulvinar sign in association with coeliac disease.

BMJ case reports·2025
Same author

Rate of change in upper and lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis.

Journal of neurology·2025
Same author

Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.

Physical review letters·2024
Same author

Tinkering with care: Implementing extended-release buprenorphine depot treatment for opioid dependence.

The International journal on drug policy·2024
Same author

Rare Variant of Lateral Medullary Syndrome; Opalski Syndrome with Cerebellar Infarction.

Irish medical journal·2023
Same journal

Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis Registry.

Neurology·2026
Same journal

Association of Changes in Intrinsic Capacity With Cognitive Decline and Dementia: A Prospective Cohort Study.

Neurology·2026
Same journal

Role of the Upper Motor Neuron in the Generation of Fasciculations in Early Disease Stages of Amyotrophic Lateral Sclerosis.

Neurology·2026
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
See all related articles

Thyrotoxicosis can cause inflammatory myopathy, leading to muscle weakness. This case study shows complete recovery without steroids, suggesting an alternative treatment approach for this condition.

Area of Science:

  • Endocrinology
  • Neurology
  • Pathology

Background:

  • Inflammatory myopathies can be associated with endocrine disorders.
  • Thyrotoxicosis, characterized by elevated thyroid hormones, can manifest with neuromuscular symptoms.

Observation:

  • A 45-year-old male presented with episodic muscle weakness, hip flexor weakness (MRC grade 4/5), elevated creatine kinase (CK), and inflammatory myopathy.
  • Diagnostic workup revealed elevated free thyroxine (FT4) and triiodothyronine (T3) levels, indicating thyrotoxicosis.

Findings:

  • Treatment with carbimazole led to complete resolution of muscle weakness and normalization of muscle power.
  • Repeat muscle biopsy showed resolution of inflammatory endomysial infiltrates and absence of necrosis, indicating complete pathologic recovery.

Related Experiment Videos

  • This represents the first reported case of complete clinical and pathological resolution of thyrotoxicosis-associated inflammatory myopathy without corticosteroid therapy.

    • Implications:

    • Steroids may not be essential for managing thyrotoxicosis-associated inflammatory myopathy.
    • Antithyroid treatment alone can potentially resolve this specific type of myopathy.
    • This finding could alter clinical management guidelines for inflammatory myopathies linked to thyroid dysfunction.